US103545A - Improved medical compound - Google Patents
Improved medical compound Download PDFInfo
- Publication number
- US103545A US103545A US103545DA US103545A US 103545 A US103545 A US 103545A US 103545D A US103545D A US 103545DA US 103545 A US103545 A US 103545A
- Authority
- US
- United States
- Prior art keywords
- improved medical
- medical compound
- compound
- philip
- becker
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000001875 compounds Chemical class 0.000 title description 4
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 235000001258 Cinchona calisaya Nutrition 0.000 description 1
- 244000182633 Cinchona succirubra Species 0.000 description 1
- 235000006768 Cinchona succirubra Nutrition 0.000 description 1
- 101100476962 Drosophila melanogaster Sirup gene Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 240000001238 Gaultheria procumbens Species 0.000 description 1
- 235000007297 Gaultheria procumbens Nutrition 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000219061 Rheum Species 0.000 description 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 description 1
- GZCGUPFRVQAUEE-SLPGGIOYSA-N aldehydo-D-glucose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-SLPGGIOYSA-N 0.000 description 1
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 229960000948 quinine Drugs 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
Definitions
- This invention consists in a new compound of medicinal substances for the cure of fever and ague, and other kindred diseases, the said substances being as follows, mixed in the quantities, or thereabout, as stated: quinine, one dram; Peruvian bark, one ounce; rhubarb, one-half ounce; alcohol, one gill; water, one gill; winter-green, (liquid,) one tea-spoonful; molasses or sirup, (best,) one quart, to be mixed in a bottle and kept in a cool place, and to be administered about a half-hour before meals, three times a day, about a tablespoonful to a dose.
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
UNITED STATES PATENT OFFICE.
PHILIP BECKER, OF SOUTH BETHLEHEM, PENNSYLVANIA.
IMPROVED MEDICAL COMPOUND.
Specification forming part of Letters Patent No. 103, 545, dated May 31, 1870.
To all whom it may concern:
Be it known that I, PHILIP BECKER, of South Bethlehem, in the county of N orthampton and State of Pennsylvania, have invented a new and Improved Medical Compound; and I do hereby declare that the following is a full, clear, and exact description thereof, which will enable others skilled in the art to make and use the same.
This invention consists in a new compound of medicinal substances for the cure of fever and ague, and other kindred diseases, the said substances being as follows, mixed in the quantities, or thereabout, as stated: quinine, one dram; Peruvian bark, one ounce; rhubarb, one-half ounce; alcohol, one gill; water, one gill; winter-green, (liquid,) one tea-spoonful; molasses or sirup, (best,) one quart, to be mixed in a bottle and kept in a cool place, and to be administered about a half-hour before meals, three times a day, about a tablespoonful to a dose.
If the medicine thus described is taken when the disease first sets in, three doses will be sufficient to check it; but it will be necessary to continue the cure a few days.
Before taking the medicine, and while taking it, a powerful physio should be taken to carry off the disease, according to the character and nature of the malady and the constitution of the patient. The use of the medicine should be continued from two to four days.
Having thus described my invention, I claim as new and desire to secure by Letters Patent- The improved medical compound, consisting of the above-described ingredients, mixed in about the proportions specified.
PHILIP BECKER.
WVitnesses:
H. J. REEDER, A. PoYoK, J AGOB 'ZoRN.
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US103545A true US103545A (en) | 1870-05-31 |
Family
ID=2173030
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US103545D Expired - Lifetime US103545A (en) | Improved medical compound |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | US103545A (en) |
-
0
- US US103545D patent/US103545A/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kew et al. | Arsenic and mercury intoxication due to Indian ethnic remedies | |
| Cupp | Herbal remedies: adverse effects and drug interactions | |
| Berning et al. | Long-term safety of ofloxacin and ciprofloxacin in the treatment of mycobacterial infections. | |
| Fallah et al. | Efficacy of topiramate alone and topiramate plus vitamin D3 in the prophylaxis of pediatric migraine: a randomized clinical trial | |
| Krudsood et al. | Comparative clinical trial of two-fixed combinations dihydroartemisinin-napthoquine-trimethoprim (DNP®) and artemether-lumefantrine (Coartem®/Riamet®) in the treatment of acute uncomplicated falciparum malaria in Thailand | |
| Munster et al. | Imipramine (Tofrānil) in the treatment of enuresis | |
| US103545A (en) | Improved medical compound | |
| FR3021224A1 (en) | PHYTOMEDICAMENT FOR HIV | |
| MAY et al. | Parkinsonian reactions following chlorpromazine and reserpine: similar reactions in the same patients | |
| DENBER et al. | Problems in evaluation of R-1625 | |
| Gupta et al. | Itraconazole pulse therapy is effective in dermatophyte onychomycosis of the toenail: a double-blind placebo-controlled study | |
| Brunel et al. | A double‐blind, placebo controlled, randomized trial to assess the impact of a monthly administration of 50,000 IU of vitamin D3 for 6 months on serum levels of 25‐hydroxyvitamin D in healthy young adults | |
| Cortés‐Moreno et al. | Anorectic efficacy and safety of the diethylpropion‐topiramate combination in rats | |
| US102686A (en) | Improvement in compounds for treating- rheumatism | |
| IL94601A (en) | Pharmaceutical compositions comprising naftopidil for therapy of dysuria | |
| OLTMAN et al. | Further report on protein-bound iodine in patients receiving perphenazine | |
| DARLING | Isocarboxazid (Marplan) in ambulatory psychiatric patients | |
| US113713A (en) | Improvement in medical compounds or bitters | |
| US117870A (en) | Improvement in medical compounds for treating rheumatism | |
| US90962A (en) | Improved medical compound | |
| Pehrson et al. | Treatment with praziquantel in a patient with schistosomiasis and chronic renal failure | |
| US79641A (en) | Improved oathaetio igzenge | |
| US111655A (en) | Improvement in medical compounds | |
| US107024A (en) | Improvement in medical compound tor the cure op fever and ague | |
| US71549A (en) | Executrix |